United States · FDA National Drug Code directory
LORAZEPAM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-229_e2bf4a43-faf3-433b-8f77-8d5d03600845
- Product NDC
- 71610-229
- Form
- TABLET
- Composition / generic term
- LORAZEPAM
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170324
- Source listing expiry
- 20261231
Source-listed ingredients
- LORAZEPAM — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 BOTTLE (71610-229-10) · 71610-229-10
- 15 TABLET in 1 BOTTLE (71610-229-15) · 71610-229-15
- 30 TABLET in 1 BOTTLE (71610-229-30) · 71610-229-30
- 45 TABLET in 1 BOTTLE (71610-229-45) · 71610-229-45
- 60 TABLET in 1 BOTTLE (71610-229-53) · 71610-229-53
- 75 TABLET in 1 BOTTLE (71610-229-55) · 71610-229-55
- 90 TABLET in 1 BOTTLE (71610-229-60) · 71610-229-60
- 120 TABLET in 1 BOTTLE (71610-229-70) · 71610-229-70
- 150 TABLET in 1 BOTTLE (71610-229-75) · 71610-229-75
- 180 TABLET in 1 BOTTLE (71610-229-80) · 71610-229-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →